Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication

Pharmacopsychiatry

Volumn 40, Issue 4, 2007, Pages 140-145

  Westheide, J ^a   Cohen, S ^f   Bender, S ^b   Cooper Mahkorn, D ^a   Erfurth, A ^d   Gastpar, M ^b   Huber, T J ^g   Maier, W ^a   Murafi, A ^d   Rothermund, M ^c   Signerski, J ^b   Strater B ^a   Teusch, L ^d   Weig, W ^e   Welling, A ^e   Kuhn K U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Department of Psychiatry and Psychotherapy   (Germany)

^e State Hospital for Psychiatry Osnabrueck   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; ZOTEPINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; ORGASM DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL DYSFUNCTION;

ADULT; ANTIPSYCHOTIC AGENTS; HUMANS; LIBIDO; MALE; PROLACTIN; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 34547903426     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981480     Document Type: Article

References (28)

1. Aichhorn W, Whitworth AB, Weiss EM, Marksteiner J. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Saf 2006; 29: 587-598
2. Aizenberg D, Modai I, Landa A, Gil-Ad I, Weizman A. Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry 2001; 62: 541-544
3. Baldwin DS, Mayers A. Sexual side-effects of antidepressant and antipsychotic drugs. Advances in Psychiatric Treatment 2003; 9: 202-210
4. Bender S, Grohmann R, Engel RR, Degner D, Dittmann-Balcar A, Ruther E. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics. Pharmacopsychiatry 2004; 37 (Suppl 1): S46-53
5. Bobes J, Garc A-Portilla MP, Rejas J, Hern Ndez G, Garcia-Garcia M, Rico-Villademoros F, Porras A. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 2003; 29: 125-147
6. Byerly MJ, Nakonezny PA, Bettcher BM, Carmody T, Fisher R, Rush AJ. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophr Res 2006; 86: 244-250
7. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63: 357-366
8. Cohen S, Huber TJ. Stichtagserhebung zu Störungen der Sexualität bei stationär behandelten, psychisch kranken Menschen. Nervenarzt 2006, in press
9. Cohen S, Kühn KU, Bender S, Erfurth A, Gastpar M, Murafi A, Rothermund M, Signerski J, Sträter B, Teusch L, Weig W, Welling A, Westheide J, Huber TJ. Sexual impairment in psychiatric inpatients: Focus on depression. Pharmacopsychiatry 2007, in press
10. Costa AM, de Lima MS, Faria M, Rodrigues Filho S, De Oliveira IR, Mari JD. A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia. J Psychopharmacol 2006, [epub ahead of print]
11. Cutler AJ. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 2003; 28 (Suppl 1): 69-82
12. Dickson RA, Glazer WM. Hyperprolactinemia and male sexual dysfunction. J Clin Psychiatry 1999; 60: 125
13. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006; 21: 251-258
14. Fortier P, Mottard JP, Trudel G, Even S. Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults. Schizophr Bull 2003; 29: 559-572
15. Goodnick PJ, Rodriguez L, Santana O. Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother 2002; 3: 1381-1391
16. Grohmann R, Engel RR, Ruther E, Hippius H. The AMSP drug safety program: methods and global results. Pharmacopsychiatry 2004; 37 Suppl 1: S4-11
17. Hellewell JS. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward. J Clin Psychiatry 1999; 60 (Suppl 23): 14-19
18. Hummer M, Huber J. Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Curr Med Res Opin 2004; 20: 189-197
19. Karow A, Schnedler D, Naber D. What would the patient choose? Subjective comparison of atypical and typical neuroleptics. Pharmacopsychiatry 2006; 39: 47-51
20. Kühn KU, Westheide J. Pharmakoinduzierte Sexualstö rungen. In: Linden M, Walter W, Rehabilitationspsychopharmakotherapie. Köln: Deutscher Ärzte Verlag, 2005; 337-354
21. Maguire GA. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J Clin Psychiatry 2002; 63 (Suppl 4): 56-62
22. MacGrath BM, Tempier RP. Patients' opinions of olanzapine and risperidone following long-term treatment: Results from a cross-sectional survey. Pharmacopsychiatry 2005; 38: 147-157
23. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001; 62 (Suppl 3): 10-21
24. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002; 63: 1121-1128
25. Smith S, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002; 181: 49-55
26. Tenback DE, van Harten PN, Slooff CJ, van Os J. Tardive dyskinesia in schizophrenia is associated with prolactin-related sexual disturbances. Neuropsychopharmacology 2006; 31: 1832-1837
27. Weig W. Sexuelle Dysfunktionen aus nervenärztlicher Perspektive. Nervenarzt 2006; 77: 101-109
28. Wirshing DA, Pierre JM, Marder SR, Saunders CS, Wirshing WC. Sexual side effects of novel antipsychotic medications. Schizophr Res 2002; 56: 25-30